Systemic Immunomodulatory Treatments for Patients With Atopic Dermatitis | Zendy

Aaron M. Drucker | Zendy; Alexandra G. Ellis | Zendy; Michal Bohdanowicz | Zendy; Soudeh Mashayekhi | Zendy; Z.Z.N. Yiu | Zendy; Bram Rochwerg | Zendy; Sonya Di Giorgio | Zendy; B.W.M. Arents | Zendy; Tim Burton | Zendy; Phyllis I. Spuls | Zendy; Denise Küster | Zendy; Doreen Siegels | Zendy; Jochen Schmitt | Zendy; Carsten Flohr | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Systemic Immunomodulatory Treatments for Patients With Atopic Dermatitis

Author(s) -

Aaron M. Drucker,

Alexandra G. Ellis,

Michal Bohdanowicz,

Soudeh Mashayekhi,

Z.Z.N. Yiu,

Bram Rochwerg,

Sonya Di Giorgio,

B.W.M. Arents,

Tim Burton,

Phyllis I. Spuls,

Denise Küster,

Doreen Siegels,

Jochen Schmitt,

Carsten Flohr

Publication year - 2020

Publication title -

jama dermatology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.128

H-Index - 166

eISSN - 2168-6084

pISSN - 2168-6068

DOI - 10.1001/jamadermatol.2020.0796

Subject(s) - medicine , atopic dermatitis , placebo , clinical trial , eczema area and severity index , randomized controlled trial , adverse effect , medline , meta analysis , dermatology life quality index , dermatology , disease , alternative medicine , pathology , political science , law

Most clinical trials assessing systemic immunomodulatory treatments for patients with atopic dermatitis are placebo-controlled.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research